[Treatment of hepatitis E virus infection].
作者信息
Kamar Nassim, Rostaing Lionel, Alric Laurent, Peron Jean-Marie, Izopet Jacques
机构信息
CHU de Toulouse, hôpital Rangueil, département de néphrologie et transplantation d'organes, 31059 Toulouse cedex 9, France; Université Paul-Sabatier, 31062 Toulouse, France; Inserm U1043, IFR-BMT, hôpital Purpan, 31059 Toulouse cedex 9, France.
CHU de Toulouse, hôpital Rangueil, département de néphrologie et transplantation d'organes, 31059 Toulouse cedex 9, France; Université Paul-Sabatier, 31062 Toulouse, France; Inserm U1043, IFR-BMT, hôpital Purpan, 31059 Toulouse cedex 9, France.
出版信息
Presse Med. 2015 Mar;44(3):339-42. doi: 10.1016/j.lpm.2014.10.011. Epub 2015 Jan 29.
The reduction of immunosuppressive therapy is the first-line therapeutic option in transplant-patients with chronic hepatitis E virus infection. Pegylated-interferon has been used for treating hepatitis E virus infection. Ribavirin alone is the treatment of choice of hepatitis E virus infection. Ribavirin is efficient for treating chronic hepatitis E in transplant patients, HIV patients, and hematology patients receiving or not chemotherapy. Ribavirin should be given to patients presenting hepatitis E virus associated extra-hepatic manifestations. The place of ribavirin therapy at acute phase is yet to be determined.
Zotero 插件